Further investigation of the regulatory mechanisms governing aberrant expression of TSLP found the increased presence of miR-19b-5p in all thymoma patients compared with healthy controls, with a significant difference in levels between TAMG patients and thymoma patients without myasthenia gravis. The gene discussed is TSLP; the disease is thymoma.